Korea’s MFDS Recalls Garcinia Cambogia Supplements After Reported Liver Injury Cases

Reporter Kim Jisun / approved : 2025-09-24 03:37:31
  • -
  • +
  • 인쇄

Daewoong Pharmaceutical’s “Garcinia” dietary supplement (Photo = Ministry of Food and Drug Safety, Korea)]

 

 

 

[Alpha Biz= Kim Jisun] Seoul, September 23, 2025 – The Ministry of Food and Drug Safety (MFDS) announced a full recall of certain Garcinia cambogia extract-based dietary supplements following reports of liver damage linked to their consumption.



According to the MFDS, two separate consumers experienced hepatitis-like symptoms on August 25 and 27 after ingesting Garcinia supplements shortly after alcohol consumption. Following review, the Health Functional Food Deliberation Committee concluded that the causal relationship between the product and the adverse events was “very high” (Grade 5).



The affected products are “Garcinia” supplements manufactured by Natural Way and distributed by Daewoong Pharmaceutical, with expiration dates of April 17–18, 2027.



Safety Measures and Labeling Update

Although neither MFDS inspections nor independent quality tests detected any violations of safety standards, the ministry has mandated precautionary measures to protect consumers. Going forward, Garcinia cambogia extract products must carry the warning:



“May rarely cause liver injury. Avoid alcohol consumption during use.”

MFDS also announced plans to collect additional domestic and international case reports through next year to further evaluate the causal link between alcohol use and liver damage.



Company Response

Daewoong Pharmaceutical, which distributed the product, voluntarily initiated a full recall and refund process on September 2. The company stated,



“Independent testing by accredited agencies found no abnormalities. However, we proactively recalled the product to ensure customer safety. Given that the reported cases involved concurrent alcohol consumption, we believe the reaction may be related to the raw ingredient’s characteristics. We will fully cooperate with MFDS should it conduct a re-evaluation of ingredient safety.”



Consumer Advisory

Authorities urged consumers to immediately stop taking the recalled product and return it to the point of purchase for a refund. MFDS also warned that excessive intake of fat-reduction supplements or combining them with other similar products may increase health risks, advising consumers to strictly follow recommended dosages and usage instructions.

 

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Shinhan Investment Raises LG Innotek Target Price to ₩280,000 on Earnings Recovery and 2025 Growth Outlook2025.10.31
Woori Bank Sanctioned by Financial Supervisory Service for Delayed Reporting of Overseas Regulatory Actions2025.10.31
Samyang Foods Raises U.S. Supply Prices for Buldak Ramen Amid Tariff Impact2025.10.31
NH Investment & Securities Suspends IB Executive Under Investigation for Alleged Insider Trading2025.10.31
Heungkuk Life to Secure KRW 840 Billion in Liquidity Through Headquarters Sale and Bond Issuance — Preparing for AIGIS Asset Management Acquisition Bid2025.10.31
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사